Table of Contents Table of Contents
Previous Page  68 / 1082 Next Page
Information
Show Menu
Previous Page 68 / 1082 Next Page
Page Background

S55

ESTRO 36 2017

_______________________________________________________________________________________________

A. Rühle

1

, R. Lopez Perez

1

, K.J. Weber

2

, J. Debus

1,2

, P.E.

Huber

1,2

, N.H. Nicolay

1,2

1

German Cancer Research Center, Radiation Oncology,

Heidelberg, Germany

2

University Hospital, Radiation Oncology, Heidelberg,

Germany

Purpose or Objective

Mesenchymal stem cells (MSCs) have been shown to aid

the regeneration of tissue damage induced by ionizing

radiation or cisplatin. While these stem cells are relatively

resistant to photon irradiation and cisplatin treatment

alone, the influence of clinically relevant cisplatin-based

chemo-radiation regimes on the survival and functional

abilities of MSCs is unknown.

Material and Methods

The survival of human bone marrow-derived MSCs was

assessed after pre-treatment with different doses of

cisplatin, and the influence of cisplatin chemo-radiation

on cellular morphology, adhesion and migratory abilities

and differentiation potential was analyzed. Cell cycle

distribution and apoptosis levels of MSCs were measured

using flow cytometry, and DNA double strand break repair

capacities were evaluated by immunofluorescence.

Results

Cisplatin pre-treatment resulted in a dose-dependent

radiosensitization with sensitizer enhancement ratio

values ranging between 1.07 and 1.30 depending on the

cisplatin treatment dose. Cellular morphology, adhesion

and migratory abilities were not significantly influenced

by cisplatin chemo-radiation. MSC differentiation

capability along the adipogenic and chondrogenic lineages

was preserved after chemo-radiation, and the defining

stem cell surface markers were stably expressed

irrespective of treatment. Cisplatin pre-treatment

resulted in an accumulation of MSCs in the radiosensitive

G2/M phase of the cell cycle. Immunofluorescence

analyses showed an increase in both initial and residual

radiation-induced DNA double strand breaks following pre-

treatment with cisplatin.

Conclusion

We could demonstrate for the first time that pre-

treatment with cisplatin resulted in a dose-dependent

sensitization of radioresistant MSCs, whereas the defining

stem cell characteristics of the stem cells were largely

preserved. A cisplatin-mediated G2/M phase arrest and an

increase in residual radiation-induced DNA double strand

breaks may at least be partly responsible for the

radiosensitizing effect of cisplatin in MSCs.

OC-0118 Mesenchymal stem cells are resistant to

ionizing radiation irrespective of their tissue of origin

N.H. Nicolay

1,2

, A. Rühle

2

, O. Xia

2

, R. Lopez Perez

2

, J.

Debus

1,2

, P.E. Huber

1,2

1

University Hospital, Radiation Oncology, Heidelberg,

Germany

2

German Cancer Research Center, Radiation Oncology,

Heidelberg, Germany

Purpose or Objective

Mesenchymal stem cell-based therapies may provide a

novel approach to treat radiation-induced organ damage.

While mesenchymal stem cells (MSCs) required for those

potential treatments can be harvested from various

different tissues, the influence of ionizing radiation on the

stem cells from diverse original tissues themselves is

largely unknown.

Material and Methods

The radiation response of MSCs isolated from human bone

marrow, adipose tissue and umbilical cord was

investigated. Cellular survival, cell cycle effects and

apoptosis were measured and compared to that of

differentiated fibroblasts. The influence of irradiation on

the defining stem cell properties was assessed, and the

radiation effects on MSC morphology, surface marker

expression, adhesion and migration capabilities and the

differentiation potential were measured.

Immunocytochemical analyses of DNA damage and repair

foci were carried out to quantify the MSCs' ability for DNA

double strand break repair.

Results

MSCs from different tissues were found to exhibit a

relative radiation resistance comparable to that of

differentiated fibroblasts. Irradiated MSCs demonstrated a

prolonged arrest in G2 phase of the cell cycle, but were

able to avoid induction of apoptosis even after treatment

with high radiation doses. Surface marker expression,

stem cell adhesion and migration capability were not

generally reduced by irradiation, and MSCs also

maintained their potential for adipogenic, osteogenic and

chondrogenic differentiation. Analysis of DNA

damage/repair foci demonstrated a swift and efficient

repair of radiation-induced DNA double strand breaks in

MSCs, providing an explanation for the observed radiation

resistance of these stem cells.

Conclusion

These data demonstrate for the first time that MSCs from

diverse human tissues exhibit comparable resistance to

ionizing radiation and also largely maintain their defining

stem cell characteristics independent of their original

tissue. The observed radiation resistance of MSCs from

different tissues will help to establish diverse stem cell

sources for future MSC-based therapies against radiation-

induced organ damage.

OC-0119 Dermatan sulfate mitigates radiation-induced

oral mucositis (mouse) – biological mechanisms

S. Gruber

1

, E. Bozsaky

1

, M. Arnold

1

, S. Pfaffinger

1

, S.

Hetzendorfer

1

, V. Gernedl

1

, A. Rohorzka

1

, L. Kowald

1

, S.

Morava

1

, J. Mayer

1

, P. Kuess

1

, W. Dörr

1

1

Medizinische Universität Wien Medical University of

Vienna, Univ.Klinik f. Strahlentherapie, Vienna, Austria

Purpose or Objective

Oral mucositis is the most frequent,

dose limiting early adverse event of head-and-neck cancer

radio(chemo)therapy. The present study quantified the

mucoprotective effect of dermatan sulfate (DS) and

characterised the underlying biological mechanisms.

Irradiation- and DS-mediated changes of epithelial

proliferation, cell junction formation, inflammation and

hypoxia were investigated.

Material and Methods

The study comprises functional and mechanistic

investigations. For the functional assessment of mucosal

ulcer incidence and time course, mice were irradiated

with 5x3 Gy/week over one (days 0-4) or two weeks (days

0-4, 7-11). Each protocol was concluded by graded top-up

doses (day 7/14) to generate complete dose-effect curves.

Daily doses of DS (4 mg/kg subcutaneously) were applied

over varying time intervals during either the first or the

second week of fractionation alone, or during both weeks,

respectively. In the mechanistic analyses, groups of five

mice per experimental arm were sacrificed every second

day during the two week fractionated irradiation, the

tongues were excised and subjected to histological /

immunohistochemical processing.

Results

DS significantly increased the isoeffective doses for the

induction of oral mucositis in almost all protocols. DS

furthermore prolonged the latency to epithelial ulceration

and reduced ulcer duration. Proliferation measurements

did not show any substantial or systematical effect of DS.

In contrast, the radiation-induced increase in the

expression of the adherens junction proteins e-cadherin

and β-catenin as well as the tight junction proteins claudin

and occludin occurred significantly earlier and more

pronounced with additional DS treatment. The expression

of IL-1β and NF-κB as markers of inflammation was

dramatically increased during irradiation alone; while DS

treatment significantly inhibited the radiation-induced